Hisamitsu Pharmaceutical Co (FSE:4530) E10: 円218.04 (As of Nov. 2025)


FSE:4530 Hisamitsu Pharmaceutical Co Inc FSE:4530
89 GF Score
Price 円3,975.00
GF Value 円3,237.07
View Full Analysis

What is Hisamitsu Pharmaceutical Co E10?

Hisamitsu Pharmaceutical Co FSE:4530 89 E10 is 円218.04 as of Nov. 2025. GuruFocus rates FSE:4530 with a GF Score™ of 89/100 and a GF Value™ of 円3,237.07.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Hisamitsu Pharmaceutical Co's adjusted earnings per share data for the three months ended in Nov. 2025 was 円68.690. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is 円218.04 for the trailing ten years ended in Nov. 2025.

During the past 12 months, Hisamitsu Pharmaceutical Co's average E10 Growth Rate was -100.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Hisamitsu Pharmaceutical Co was 1.00% per year. The lowest was -3.90% per year. And the median was -2.40% per year.

As of today (2026-06-26), Hisamitsu Pharmaceutical Co's current stock price is 円3975.00. Hisamitsu Pharmaceutical Co's E10 for the quarter that ended in Nov. 2025 was 円218.04. Hisamitsu Pharmaceutical Co's Shiller PE Ratio of today is 18.23.

During the past 13 years, the highest Shiller PE Ratio of Hisamitsu Pharmaceutical Co was 37.52. The lowest was 17.68. And the median was 22.68.


Hisamitsu Pharmaceutical Co  (FSE:4530) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Hisamitsu Pharmaceutical Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=3975.00/218.04
=18.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Hisamitsu Pharmaceutical Co was 37.52. The lowest was 17.68. And the median was 22.68.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Hisamitsu Pharmaceutical Co E10 Related Terms


Hisamitsu Pharmaceutical Co E10 Historical Data

* Premium members only.

The historical data trend for Hisamitsu Pharmaceutical Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hisamitsu Pharmaceutical Co E10 Chart

Hisamitsu Pharmaceutical Co Annual Data
Trend Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24 Feb25 Feb26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 211.15 208.76 204.84 217.33 0.00

Hisamitsu Pharmaceutical Co Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 217.33 218.12 217.12 218.04 0.00

FSE:4530 vs ZTS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Hisamitsu Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hisamitsu Pharmaceutical Co Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hisamitsu Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Hisamitsu Pharmaceutical Co's Shiller PE Ratio falls into.


FSE:4530
89GF Score
Hisamitsu Pharmaceutical Co Inc FSE:4530
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hisamitsu Pharmaceutical Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Hisamitsu Pharmaceutical Co's adjusted earnings per share data for the three months ended in Nov. 2025 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Nov. 2025 (Change)*Current CPI (Nov. 2025)
=68.69/113.2000*113.2000
=68.690

Current CPI (Nov. 2025) = 113.2000.

Hisamitsu Pharmaceutical Co Quarterly Data

per share eps CPI Adj_EPS
201602 29.270 97.800 33.879
201605 53.480 98.200 61.649
201608 55.940 97.900 64.682
201611 106.700 98.600 122.499
201702 25.030 98.100 28.883
201705 43.890 98.600 50.389
201708 68.230 98.500 78.413
201711 77.070 99.100 88.036
201802 39.160 99.500 44.552
201805 41.230 99.300 47.001
201808 68.130 99.800 77.278
201811 49.840 100.000 56.419
201902 70.660 99.700 80.228
201905 23.130 100.000 26.183
201908 68.140 100.000 77.134
201911 95.870 100.500 107.985
202002 40.160 100.300 45.325
202005 1.390 100.100 1.572
202008 43.770 100.100 49.498
202011 24.810 99.500 28.226
202102 43.140 99.800 48.932
202105 28.890 99.400 32.901
202108 32.270 99.700 36.640
202111 14.930 100.100 16.884
202202 42.750 100.700 48.057
202205 20.450 101.800 22.740
202208 61.060 102.700 67.303
202211 37.850 103.900 41.238
202302 28.520 104.000 31.043
202305 52.050 105.100 56.061
202308 56.180 105.900 60.053
202311 48.250 106.900 51.094
202402 24.940 106.900 26.410
202405 63.820 108.100 66.831
202408 58.730 109.100 60.937
202411 62.210 110.000 64.020
202502 110.390 110.800 112.781
202505 35.100 111.800 35.540
202508 61.780 112.100 62.386
202511 68.690 113.200 68.690

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of 円218.04 mean?
Hisamitsu Pharmaceutical Co (FSE:4530) has a E10 of 円218.04 as of Nov. 2025. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Hisamitsu Pharmaceutical Co and its competitors.
Is Hisamitsu Pharmaceutical Co's E10 too high?
Hisamitsu Pharmaceutical Co's current E10 is 円218.04. Overall, Hisamitsu Pharmaceutical Co has a GF Score™ of 89/100, reflecting its overall financial health beyond just this single metric.
How does Hisamitsu Pharmaceutical Co's E10 compare to ZTS?
Hisamitsu Pharmaceutical Co's E10 of 円218.04 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Hisamitsu Pharmaceutical Co and its competitors. Hisamitsu Pharmaceutical Co's current E10 is 円218.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hisamitsu Pharmaceutical Co stock overvalued right now?
Hisamitsu Pharmaceutical Co (FSE:4530) has a current E10 of 円218.04. The stock's GF Value™ is 円3,237.07, compared to a current price of 円3,975.00 — trading 22.8% above its estimated fair value. The current E10 is 円218.04. Hisamitsu Pharmaceutical Co's overall GF Score™ is 89/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Hisamitsu Pharmaceutical Co (FSE:4530), the current E10 is 円218.04 as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hisamitsu Pharmaceutical Co (FSE:4530) Overvalued in 2026?

Based on GuruFocus' analysis, Hisamitsu Pharmaceutical Co stock appears to be overvalued. The current stock price of 円3,975.00 is trading 22.8% above its estimated GF Value™ of 円3,237.07.

Key valuation signals for FSE:4530:

  • E10: 円218.04
  • GF Value™: 円3,237.07 vs. price of 円3,975.00 (22.8% above fair value)
  • GF Score™: 89/100

No single metric tells the full story. See the FSE:4530 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Hisamitsu Pharmaceutical Co Business Description

Other Exchanges HTSUY:USA
Address 408 Tashiro Daikancho, Saga Prefecture, Tosu, JPN, 841-0017
Hisamitsu Pharmaceutical Co Inc is engaged in the research, development, manufacturing, procurement, and sale of pharmaceutical products. The company operates a single business segment, focusing on medical and general pharmaceuticals both in Japan and overseas. It markets drugs under the Salonpas, Nobinobi / Salonsip, Butenalock, and Mohrus brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions, and ointments.
89GF Score

Get the complete analysis for FSE:4530

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円3,975.00
Price
円3,237.07
GF Value